Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma.
Hosseinzadeh F, Ai J, Ebrahimi-Barough S, Seyhoun I, Hajifathali A, Muhammadnejad S, Hosseinzadeh F, Shadnoush M, Dabiri Oskouei F, Verdi J. Hosseinzadeh F, et al. Among authors: seyhoun i. Asian Pac J Cancer Prev. 2019 Dec 1;20(12):3797-3803. doi: 10.31557/APJCP.2019.20.12.3797. Asian Pac J Cancer Prev. 2019. PMID: 31870124 Free PMC article.
Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of HCC.
Hajighasemlou S, Nikbakht M, Pakzad S, Muhammadnejad S, Gharibzadeh S, Mirmoghtadaei M, Zafari F, Seyhoun I, Ai J, Verdi J. Hajighasemlou S, et al. Among authors: seyhoun i. Evid Based Complement Alternat Med. 2020 Jun 14;2020:9602728. doi: 10.1155/2020/9602728. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32617114 Free PMC article.
The effects of Sorafenib and Natural killer cell co-injection in combinational treatment of hepatocellular carcinoma; an in vivo approach.
Hosseinzadeh F, Ai J, Hajifathali A, Muhammadnejad S, Ebrahimi-Barough S, Seyhoun I, Komeili Movahed T, Shirian S, Hosseinzadeh F, Ahmadpour S, Alijani M, Verdi J. Hosseinzadeh F, et al. Among authors: seyhoun i. Pharmacol Rep. 2022 Apr;74(2):379-391. doi: 10.1007/s43440-021-00335-y. Epub 2022 Jan 28. Pharmacol Rep. 2022. PMID: 35089543
Cell therapy in patients with COVID-19 using Wharton's jelly mesenchymal stem cells: a phase 1 clinical trial.
Saleh M, Vaezi AA, Aliannejad R, Sohrabpour AA, Kiaei SZF, Shadnoush M, Siavashi V, Aghaghazvini L, Khoundabi B, Abdoli S, Chahardouli B, Seyhoun I, Alijani N, Verdi J. Saleh M, et al. Among authors: seyhoun i. Stem Cell Res Ther. 2021 Jul 16;12(1):410. doi: 10.1186/s13287-021-02483-7. Stem Cell Res Ther. 2021. PMID: 34271988 Free PMC article. Clinical Trial.
12 results